Home01P • FRA
add
Medpace Holdings Inc
Previous close
€265.50
Day range
€258.10 - €265.50
Year range
€227.70 - €418.70
Market cap
8.58B USD
Avg Volume
16.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 558.57M | 9.30% |
Operating expense | 267.23M | 13.48% |
Net income | 114.60M | 11.70% |
Net profit margin | 20.52 | 2.24% |
Earnings per share | 3.67 | 14.11% |
EBITDA | 120.45M | 8.46% |
Effective tax rate | 3.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 441.44M | 8.46% |
Total assets | 1.90B | 5.66% |
Total liabilities | 1.30B | 15.97% |
Total equity | 593.61M | — |
Shares outstanding | 28.74M | — |
Price to book | 13.31 | — |
Return on assets | 14.20% | — |
Return on capital | 33.02% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 114.60M | 11.70% |
Cash from operations | 125.84M | -17.58% |
Cash from investing | -9.99M | -494.74% |
Cash from financing | -345.97M | -4,616.53% |
Net change in cash | -228.00M | -241.12% |
Free cash flow | 81.93M | -27.65% |
About
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 5,400 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016. Wikipedia
Founded
1992
Headquarters
Website
Employees
5,900